Vascular Endothelial Growth Factor (VEGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Pages: 286 Published: May 02, 2022 Report Code: GMDGDHC2904TDBOD

Vascular Endothelial Growth Factor (VEGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Vascular Endothelial Growth Factor (VEGF) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Vascular Endothelial Growth Factor (VEGF) targeted therapeutics development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note:

* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.

* Certain sections in the report may be removed or altered based on the availability and relevance of data.

* Global Markets Direct, is a research brand owned and operated by GlobalData.

Scope

– The report provides a snapshot of the Global therapeutic landscape for Vascular Endothelial Growth Factor (VEGF) .

– The report reviews Vascular Endothelial Growth Factor (VEGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

– The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive Mechanism of Action (MoA), Research and Development (R&D) brief, Licensing and Collaboration details & Other Developmental Activities.

– The report reviews key players involved in Vascular Endothelial Growth Factor (VEGF) targeted therapeutics and enlists all their major and minor projects.

– The report assesses Vascular Endothelial Growth Factor (VEGF) targeted therapeutics based on Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.

– The report summarizes all the dormant and discontinued pipeline projects.

– The report reviews latest news and deals related to Vascular Endothelial Growth Factor (VEGF) targeted therapeutics.

Reasons to Buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective Research and Development (R&D) strategies.

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Identify and understand the targeted therapy areas and indications for Vascular Endothelial Growth Factor (VEGF) . Identify the use of drugs for target identification and drug repurposing.

– Identify potential new clients or partners in the target demographic.

– Develop strategic initiatives by understanding the focus areas of leading companies.

– Plan Mergers and Acquisitions (M&A) effectively by identifying key players and it’s most promising pipeline therapeutics.

– Devise corrective measures for pipeline projects by understanding Vascular Endothelial Growth Factor (VEGF) development landscape.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Table of Contents

Introduction

Report Coverage

Target – Overview

Target – Therapeutics Development

Products under Development by Stage of Development

Products under Development by Therapy Area

Products under Development by Indication

Products under Development by Companies

Products under Development by Universities/Institutes

Target – Therapeutics Assessment

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Target – Companies Involved in Therapeutics Development

Company 1

Company 2

Company 3

Company XX

Target – Drug Profiles

Drug Profile 1

Product Description

Mechanism of Action

R&D Progress

Drug Profile 2

Product Description

Mechanism of Action

R&D Progress

Drug Profile 3

Product Description

Mechanism of Action

R&D Progress

Drug Profile XX

Product Description

Mechanism of Action

R&D Progress

Target – Dormant Products

Target – Discontinued Products

Target – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development by Stage of Development, 2022

Number of Products under Development by Therapy Areas, 2022

Number of Products under Development by Indication, 2022

Number of Products under Development by Companies, 2022

Products under Development by Companies, 2022

Number of Products under Investigation by Universities/Institutes, 2022

Products under Investigation by Universities/Institutes, 2022

Number of Products by Stage and Mechanism of Actions, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Pipeline by Company 1, 2022

Pipeline by Company 2, 2022

Pipeline by Company 3, 2022

Pipeline by Company XX, 2022

Dormant Products, 2022

Discontinued Products, 2022

List of Figures

Number of Products under Development by Stage of Development, 2022

Number of Products under Development by Therapy Areas, 2022

Number of Products under Development by Top 10 Indications, 2022

Number of Products by Stage and Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Molecule Types, 2022

$3,500

Can be used by individual purchaser only

$10,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.